Cutler Group’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-64
Closed -$1K 4305
2022
Q3
$1K Sell
64
-200
-76% -$120K ﹤0.01% 4398
2022
Q2
$6K Sell
264
-512
-66% -$259K ﹤0.01% 3542
2022
Q1
$28K Buy
776
+616
+385% +$317K ﹤0.01% 2752
2021
Q4
$1K Buy
+160
New +$97.4K ﹤0.01% 4916
2021
Q3
Sell
-160
Closed -$9K 5625
2021
Q2
$9K Buy
+160
New +$140K ﹤0.01% 3956

Other funds holding AGL

Cutler Group's AGL Position: Q2 2023 in Review

Cutler Group sold out of Agilon Health (AGL) in Q2 2023, closing a stake of 123 shares — an estimated $69.1K sold.

Cutler Group first reported a position in AGL in Q3 2021 and held it in 7 quarters. The position peaked at $194K in Q4 2022. 185 funds tracked by Wall St. Rank hold AGL as of Q2 2023.

  • Cutler Group reported no remaining Agilon Health position as of Q2 2023 after selling out during the quarter.
  • Cutler Group sold 123 Agilon Health shares in Q2 2023, an estimated $69.1K.
  • Cutler Group first reported a position in Agilon Health in Q3 2021 and held it in 7 quarters.
  • Cutler Group's Agilon Health position peaked at $194K in Q4 2022.
  • 185 funds tracked by Wall St. Rank held Agilon Health as of Q2 2023.

Based on Cutler Group's 13F filing for Q2 2023, filed 18 Jul 2023.